KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
OTCBB:REPCF

Replicel Life Science Ord Stock Price (Quote)

OTC Bulletin Board > Healthcare > Biotechnology
Open Broker Account
$0.0428
+0 (+0%)
At Close: Apr 26, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0428 $0.0428 Friday, 26th Apr 2024 REPCF stock ended at $0.0428. During the day the stock fluctuated 0% from a day low at $0.0428 to a day high of $0.0428.
90 days $0.0340 $0.0505
52 weeks $0.0257 $0.186

Historical Replicel Life Science Ord prices

Date Open High Low Close Volume
Apr 26, 2024 $0.0428 $0.0428 $0.0428 $0.0428 0
Apr 25, 2024 $0.0428 $0.0428 $0.0428 $0.0428 0
Apr 24, 2024 $0.0428 $0.0428 $0.0428 $0.0428 0
Apr 23, 2024 $0.0428 $0.0428 $0.0428 $0.0428 0
Apr 22, 2024 $0.0428 $0.0428 $0.0428 $0.0428 0
Apr 19, 2024 $0.0428 $0.0428 $0.0428 $0.0428 0
Apr 18, 2024 $0.0428 $0.0428 $0.0428 $0.0428 0
Apr 17, 2024 $0.0428 $0.0428 $0.0428 $0.0428 0
Apr 16, 2024 $0.0428 $0.0428 $0.0428 $0.0428 0
Apr 15, 2024 $0.0428 $0.0428 $0.0428 $0.0428 0
Apr 12, 2024 $0.0428 $0.0428 $0.0428 $0.0428 0
Apr 11, 2024 $0.0428 $0.0428 $0.0428 $0.0428 0
Apr 10, 2024 $0.0428 $0.0428 $0.0428 $0.0428 0
Apr 09, 2024 $0.0428 $0.0428 $0.0428 $0.0428 0
Apr 08, 2024 $0.0428 $0.0428 $0.0428 $0.0428 0
Apr 05, 2024 $0.0428 $0.0428 $0.0428 $0.0428 0
Apr 04, 2024 $0.0428 $0.0428 $0.0428 $0.0428 0
Apr 03, 2024 $0.0428 $0.0428 $0.0428 $0.0428 0
Apr 02, 2024 $0.0428 $0.0428 $0.0428 $0.0428 0
Apr 01, 2024 $0.0428 $0.0428 $0.0428 $0.0428 0
Mar 28, 2024 $0.0428 $0.0428 $0.0428 $0.0428 0
Mar 27, 2024 $0.0428 $0.0428 $0.0428 $0.0428 0
Mar 26, 2024 $0.0428 $0.0428 $0.0428 $0.0428 0
Mar 25, 2024 $0.0428 $0.0428 $0.0428 $0.0428 0
Mar 22, 2024 $0.0428 $0.0428 $0.0428 $0.0428 0
Click to get the best stock tips daily for free!

About Replicel Life Science Ord

Replicel Life Science Ord RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01 for the treatment of chronic tendinosis; RCS-01 to treat aging and sun damaged skin;... REPCF Profile

Golden Star

Ticker Date Change Price
DHT Apr 24 2.04% $11.28
MLI Apr 19 9.66% $52.28
LPLA Apr 19 1.42% $262.59
DOOR Apr 18 0.167% $131.39
LNG Apr 17 1.49% $156.81
FCN Apr 16 1.80% $207.62
ELV Apr 16 5.97% $506.97
AKR Apr 05 4.78% $16.53
ITCI Apr 05 7.04% $68.44
VSTS Apr 04 0.425% $18.82
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT